Literature DB >> 6998374

Susceptibility of Clostridium botulinum to thirteen antimicrobial agents.

J M Swenson, C Thornsberry, L M McCroskey, C L Hatheway, V R Dowell.   

Abstract

A total of 224 strains of Clostridium botulinum (including isolates from 14 patients with infant botulism and 4 with wound botulism) and 15 strains of C. sporogenes were tested by agar dilution for susceptibility to tetracycline, metronidazole, erythromycin, penicillin, rifampin, chloramphenicol, clindamycin, cephalothin, cefoxitin, vancomycin, sulfamethoxazole-trimethoprim, nalidixic acid, and gentamicin. At least 90% of the C. botulinum strains tested (except for nonproteolytic strains of toxin type F with penicillin) were susceptible to all drugs except sulfamethoxazole-trimethoprim, nalidixic acid, and gentamicin. Minimal inhibitory concentrations for strains from patients with infant and wound botulism were similar to those for other C. botulinum strains.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6998374      PMCID: PMC283932          DOI: 10.1128/AAC.18.1.13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Botulism, a complication of Clostridium botulinum wound infection.

Authors:  C G THOMAS; M F KELEHER; A P McKEE
Journal:  AMA Arch Pathol       Date:  1951-06

2.  Clostridium botulinum in a fatal wound infection.

Authors:  J B DAVIS; L H MATTMAN; M WILEY
Journal:  J Am Med Assoc       Date:  1951-06-16

3.  Susceptibility of anaerobes to cefoxitin and other cephalosporins.

Authors:  F P Tally; N V Jacobus; J G Bartlett; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1975-02       Impact factor: 5.191

4.  Diagnosis and management of infant botulism.

Authors:  R O Johnson; S A Clay; S S Arnon
Journal:  Am J Dis Child       Date:  1979-06

5.  Current trends in botulism in the United States.

Authors:  M H Merson; J M Hughes; V R Dowell; A Taylor; W H Barker; E J Gangarosa
Journal:  JAMA       Date:  1974-09-02       Impact factor: 56.272

6.  Epidemiologic, clinical and laboratory aspects of wound botulism.

Authors:  M H Merson; V R Dowell
Journal:  N Engl J Med       Date:  1973-11-08       Impact factor: 91.245

7.  Resistance of some species of Clostridium to clindamycin.

Authors:  T D Wilkins; T Thiel
Journal:  Antimicrob Agents Chemother       Date:  1973-01       Impact factor: 5.191

8.  Collaborative evaluation of a proposed reference dilution method of susceptibility testing of anaerobic bacteria.

Authors:  V L Sutter; A L Barry; T D Wilkins; R J Zabransky
Journal:  Antimicrob Agents Chemother       Date:  1979-10       Impact factor: 5.191

9.  Antimicrobial susceptibilities of anaerobic bacteria: recent clinical isolates.

Authors:  J L Staneck; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1974-09       Impact factor: 5.191

10.  Susceptibility of anaerobic bacteria to sulfamethoxazole/trimethoprim and routine susceptibility testing.

Authors:  J Wüst; T D Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

View more
  10 in total

1.  Wound botulism complicating internal fixation of a complex radial fracture.

Authors:  Steve M Taylor; Cameron R Wolfe; Terry C Dixon; David S Ruch; Gary M Cox
Journal:  J Clin Microbiol       Date:  2009-12-09       Impact factor: 5.948

Review 2.  Laboratory diagnostics of botulism.

Authors:  Miia Lindström; Hannu Korkeala
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

3.  Selection and Development of Nontoxic Nonproteolytic Clostridium botulinum Surrogate Strains for Food Challenge Testing.

Authors:  Marijke Poortmans; Kristof Vanoirbeek; Martin B Dorner; Chris W Michiels
Journal:  Foods       Date:  2022-05-27

4.  Improved selective medium for the isolation of lipase-positive Clostridium botulinum from feces of human infants.

Authors:  D C Mills; T F Midura; S S Arnon
Journal:  J Clin Microbiol       Date:  1985-06       Impact factor: 5.948

5.  Susceptibility to enteric botulinum colonization of antibiotic-treated adult mice.

Authors:  D H Burr; H Sugiyama
Journal:  Infect Immun       Date:  1982-04       Impact factor: 3.441

6.  Selective and differential medium for detecting Clostridium botulinum.

Authors:  J C Silas; J A Carpenter; M K Hamdy; M A Harrison
Journal:  Appl Environ Microbiol       Date:  1985-10       Impact factor: 4.792

7.  Antimicrobial Susceptibility of 260 Clostridium botulinum Type A, B, Ba, and Bf Strains and a Neurotoxigenic Clostridium baratii Type F Strain Isolated from California Infant Botulism Patients.

Authors:  Jason R Barash; Joe B Castles; Stephen S Arnon
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

8.  Selective medium for isolation of Clostridium botulinum from human feces.

Authors:  M Dezfulian; L M McCroskey; C L Hatheway; V R Dowell
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

9.  Clostridium botulinum - like organism bacteremia in a user of black tar heroin.

Authors:  Therese Battiola; Kristen Saad; Taylor Nelson; Nick Tinker; Aaron Crosby
Journal:  IDCases       Date:  2021-07-09

10.  Intestinal toxemia botulism in Italy, 1984-2005.

Authors:  L Fenicia; F Anniballi; P Aureli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-06       Impact factor: 5.103

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.